Cardiotoxicity of immune checkpoint inhibitors: A meta-analysis of randomized clinical trials

被引：0
|
作者：
Agostinetto, E. [1 ]
Eiger, D. [1 ]
Lambertini, M. [2 ]
Ceppi, M. [3 ]
Bruzzone, M. [3 ]
Ponde, N. F. [4 ]
Plummer, C. [5 ]
Awada, A. H. [6 ]
Piccart, M. [6 ]
de Azambuja, E. [1 ]
机构：
[1] Inst Jules Bordet, Acad Trials Promoting Team, Brussels, Belgium
[2] IRCCS Osped Policlin San Martino, Dept Med Oncol, Genoa, Italy
[3] IRCCS Osped Policlin San Martino, Unit Clin Epidemiol, Genoa, Italy
[4] AC Camargo Canc Ctr, Clin Oncol, Sao Paulo, Brazil
[5] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England
[6] Inst Jules Bordet, Oncol Dept, Brussels, Belgium
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.10.528
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
41P
引用
收藏
页码：S1432 / S1432
页数：1
相关论文
共 50 条
  • [41] Immune Checkpoint Inhibitors in Acute Myeloid Leukemia: A Meta-Analysis
    Gomez-Llobell, Marina
    Peleteiro Raindo, Andres
    Climent Medina, Jose
    Gomez Centurion, Ignacio
    Mosquera Orgueira, Adrian
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [42] Severe immune-related adverse events of immune checkpoint inhibitors for advanced non-small cell lung cancer: a network meta-analysis of randomized clinical trials
    Gu, Jingjing
    Shi, Lei
    Jiang, Xiaowen
    Wen, Jianhua
    Zheng, Xiaoming
    Cai, Hu
    Zhang, Weidong
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (09) : 2239 - 2254
  • [43] Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Advanced Non-small Cell Lung Cancer: A Network Meta-Analysis of Randomized Clinical Trials
    Zhang, Weidong
    Gu, Jingjing
    Bian, Chunming
    Huang, Guanhong
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [44] Severe immune-related adverse events of immune checkpoint inhibitors for advanced non-small cell lung cancer: a network meta-analysis of randomized clinical trials
    Jingjing Gu
    Lei Shi
    Xiaowen Jiang
    Jianhua Wen
    Xiaoming Zheng
    Hu Cai
    Weidong Zhang
    Cancer Immunology, Immunotherapy, 2022, 71 : 2239 - 2254
  • [45] Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis
    Yamada, Kayoko
    Takeuchi, Masaki
    Fukumoto, Takeshi
    Suzuki, Minako
    Kato, Ai
    Mizuki, Yuki
    Yamada, Norihiro
    Kaneko, Takeshi
    Mizuki, Nobuhisa
    Horita, Nobuyuki
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [46] Rechallenge of immune checkpoint inhibitors: A systematic review and meta-analysis
    Inno, Alessandro
    Roviello, Giandomenico
    Ghidini, Antonio
    Luciani, Andrea
    Catalano, Martina
    Gori, Stefania
    Petrelli, Fausto
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 165
  • [47] Methodological and reporting issues for meta-analysis of immune checkpoint inhibitor-associated cardiotoxicity. Letter regarding the article 'Cardiotoxicity associated with immune checkpoint inhibitor therapy: a meta-analysis'. Reply
    Rubio-Infante, Nestor
    Ramirez-Flores, Yoel A.
    Castillo, Elena C.
    Lozano, Omar
    Garcia-Rivas, Gerardo
    Torre-Amione, Guillermo
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (08) : 1450 - 1451
  • [48] Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysis
    Wu, Zhenjie
    Chen, Qi
    Qu, Le
    Li, Mingmin
    Wang, Linhui
    Mir, Maria C.
    Carbonara, Umberto
    Pandolfo, Savio D.
    Black, Peter C.
    Paul, Asit K.
    Di Lorenzo, Giuseppe
    Porpiglia, Francesco
    Mari, Andrea
    Necchi, Andrea
    Roupret, Morgan
    Psutka, Sarah P.
    Autorino, Riccardo
    EUROPEAN UROLOGY, 2022, 81 (04) : 414 - 425
  • [49] Meta-analysis of randomized clinical trials of finasteride
    Roehrborn, CG
    UROLOGY, 1998, 51 (4A) : 46 - 49
  • [50] Safety evaluation of immune checkpoint inhibitors combined with chemotherapy for the treatment of small cell lung cancer: A meta-analysis of randomized controlled trials
    Longo, Vito
    Rizzo, Alessandro
    Catino, Annamaria
    Montrone, Michele
    Galetta, Domenico
    THORACIC CANCER, 2023, 14 (11) : 1029 - 1035
12345